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INTRODUCTION 
Myocardial Infarction is a serious complication of Atherosclerotic 
Coronary Heart Disease. Coronary Heart Disease was first described by 
William Herberden in 1768. In 1932 unipolar leads were discovered by 
Wilson and the establishment of coronary care units by Day and Brown 
has lead to the world wide proliferation of coronary care units. The 
current knowledge of pathophysiology of acute myocardial infarction 
started with the autopsy description of Dr. James Herrick from Chicago 
in 1912 who concluded that acute myocardial infarction results from 
thrombotic occlusion of coronary artery and prophesised that the hope 
of salvaging the muscle, lay in restoration of blood flow. 
Despite impressive strides in diagnosis and management over the 
last three decades, acute myocardial infarction (AMI) continues to be a 
major public health problem even in the industrialized world. In the 
United States nearly 1.5 million patients annually suffer from AMI 
(about one patient every 20 seconds).1 Myocardial Infarction2 is an acute 
cardiac disability arising from reduction or arrest of blood supply to the 
myocardium due to atherosclerotic or non-atherosclerotic lesions of 
coronary arteries. Virtually all acute infarcts are caused by thrombosis 
developing in a culprit vessel with ruptured atherosclerotic plaque. 
Usually coronary artery occlusion is associated with infarction of 
myocardium, though post-mortem examination of cases of sudden 
deaths reveals evidence in only 20% of cases, the remaining 80% do not 
show any change. 
Accurate diagnosis is mandatory because mistaken diagnosis can be 
disastrous to the social, economical and family life of the patient. At one 
end of the spectrum is the danger of missing a potentially lethal illness, 
on the other hand mistaken diagnosis results in severe cardiac neurosis 
which is even more difficult to treat than the original disease itself. 
The presenting symptoms may vary from severe pain in the chest 
to minimal symptoms, with the disease remaining unrecognized. In most 
patients there is a substernal heaviness3 which radiates to the left 
shoulder or ulnar surface of forearm and hand. It can also radiate to 
back, interscapular region, root of neck, jaw and teeth. In others it 
presents as breathlessness, syncope, giddiness, fatigue, abdominal pain, 
nausea, vomiting and unexplained hypotension. 
Coronary Heart Disease is more age dependant in women than in 
men. Women are usually 10 years older than men when any coronary 
manifestation first appears and Myocardial Infarction occurs as much as 
20 years later 4. Coronary Heart Disease is the leading cause of death in 
women and the lifetime risk of death is 31% in postmenopausal women. 
The median age of menopause is 51.4 years5 and age distribution ranges 
from 40-58 years.  
Data from Framingham study says that the incidence of 
cardiovascular disease is 3 times more in men than women(before 
menopause) and approximately equal in men and women aged 75-79 
years. The incidence in women rises after menopause due to hormonal 
changes 
Overall mortality and morbidity in coronary heart disease depends on 
age, sex, site and extent of infarction, presence of good collateral 
circulation and associated co-morbid conditions. 
Reperfusion strategies no doubt have resulted in nearly 50% 
reduction in in-hospital mortality of patients with AMI(1). Still the early 
mortality (30 days mortality) rate from AMI remains 30% and 1 in 25 
patients who survive initial hospitalization die in the first year following 
AMI (1). Several factors that affect the early mortality after AMI like age, 
left ventricular dysfunction previous CAD, diabetes mellitus, 
hypertension, fibrinolysis, anterior wall infarction were extensively 
studied worldwide so far. 
“Hyponatremia is the most commonly identified electrolyte 
abnormality in hospitalized patients” as per J.A. Clayton et al.(2). 
Gill G. et al.(3) in there study found that severe hyponatremia in 
hospitalized patients was associated with increased mortality. 
Lee WH et al.(4) states that hyponatremia is an independent risk 
factor for increased mortality among CCF patients.(33,34) 
Goldberg et al.(5) and Svanegaard et al.(6) predicted that neuro - 
humoral activation similar to that of CCF occurs in AMI patients due to 
pain, stress, nausea and acute LV dysfunction. 
Hence, it sounds worthy for me to take up a study to correlate the 
presence or development of hyponatremia among hospitalized patients of 
acute ST elevation myocardial infarction (Acute STEMI) with the short 
term (30 days) mortality of patients so that the prediction of 
hyponatremia as the independent risk factor for 30 days mortality among 
acute STEMI patients can be made possible. 
 
 
 
 
 
 
 AIM OF THE STUDY 
 
1. To correlate hyponatremia on admission or developed during the 
first 72 hours with cardiac events, like rhythm disturbances, LV 
dysfunction among the hospitalized patients of acute STEMI. 
 
2. To correlate hyponatremia on admission or developed during the 
first 72 hours among the hospitalized patients of acute STEMI with 
short-term (30 days) mortality. 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
 
A. ANATOMY OF CORONARY CIRCULATION 
 
         The epicardial coronary arteries take origin from the right and left 
coronary sinuses. In 85% of patient the right coronary artery which 
gives rise to posterior descending artery supplies the entire right 
ventricle and large a part of the posterior wall of the left ventricle. This 
is referred to as right dominant circulation. 
 In 8% of patients the left coronary artery supplies entire left 
ventricle, interventricular septum and portion of right ventricle. This is 
referred to as left dominant circulation. 
In 7% of patients referred to as co-dominant circulation, the right 
coronary artery supplies right ventricle and posterior wall of 
interventricular  septum while left coronary supplies the left ventricle 
and anterior portion of interventricular septum. 
 
 
 
Table 1: RISK FACTORS FOR CORONARY HEART 
DISEASE 
 
 
A. FIXED 
1. Age 
2. Male sex 
3. Family History 
B. MODIFIABLE 
1. Smoking 
2. Hypertension 
3. Lipid Disorders 
4. Diabetes Mellitus 
5.Haemostatic variables 
6. Sedentary Life Style 
7. Obesity 
8. Mental Stress 
9. Personality 
10. Oral Contraceptive Pills 
11. Hyperhomocysteinemia 
12. Inflammation 
 E.INVESTIGATIONS 
1. LABORATORY FINDINGS: 
  Myoglobin levels are the earliest to rise. Creatine Kinase 
starts to rise at 4 hours, peaks at about 12 hours falls to normal levels 
within 48-72 hours 45. The most sensitive markers of myocardial cell 
damage are the Cardiac Troponins T and I which are released within 4-6 
hours and remain elevated for upto 2 weeks. Myoglobin levels peak at 6 
hours and returns to normal at 24 hours. Aspartate transaminase starts to 
rise about 12 hours after infarction and reaches peak on the first or 
second day returning to normal within 3 or 4 days. Lactate 
dehydrogenase peaks at 3-4 days remains elevated for upto 10 days. 
 Lipid profile (cholesterol – total, LDL & triglycerides) may 
be raised. Leukocytosis is usual, reaching a peak on the first day. 
The ESR becomes raised. 
 
2. CHEST RADIOGRAPHY(Fig 1): 
 Chest X-ray is important since it may show the consequences of 
ischaemic heart disease i.e. cardiac enlargement, ventricular aneurysm, 
signs of heart failure and pericardial effusion. These signs can support 
the diagnosis of ischaemic heart disease and are important in assessing 
the degree of cardiac damage. 
3. ELECTROCARDIOGRAPHY:(PH 2 – 7 ) 
 The ECG is usually a sensitive and specific way of confirming the 
diagnosis; however it may be difficult to interpret if there is bundle 
branch block or evidence of previous myocardial infarction. 
Occasionally the initial ECG is normal and the diagnostic changes 
appear a few hours later. The earliest ECG change is tall and widened T 
waves followed by ST elevation. Later on there is diminution in the size 
of R wave and in full thickness infarction a Q wave begins to develop. 
Subsequently T wave becomes inverted. 
 When there has been anteroseptal infarction abnormalities are 
found in one or more leads from V1 to V4, while Anterolateral 
Infarction produces abnormalities in V4-V6, aVL and in lead I. Inferior 
Wall Infarction is best shown in lead II, III and aVF, while at the same 
time leads I, aVL and the anterior chest leads may show reciprocal 
changes of ST depression. Infarction of the posterior wall of the left 
ventricle is not recorded in the standard leads by ST elevation or Q 
waves, but the reciprocal changes of ST depression and a tall R wave 
may be seen in leads V1-V3. Right ventricular infarction should be 
strongly suspected if, in the clinical setting of acute inferior wall 
myocardial infarction, there is ST elevation of 1mm or more in lead 
V1,V4R or any of the extra right precordial leads V4R-V6R. 
4. ECHOCARDIOGRAPHY(PH 2): 
 Two dimensional echocardiography can be done to assess the 
cardiac chamber size, regional wall motion abnormalities, left 
ventricular hypertrophy, valve leaflet thickness and mobility, valve 
calcification, appearance of subvalvular and supravalvular structures, 
pericardial effusion, intracardiac masses and great vessels. 
  Doppler echocardiography is done to assess valve regurgitation, 
valve stenosis, valve area, valve gradients, intracardiac pressures, 
intracardiac shunts and ventricular diastolic filling. 
 Transesophageal echocardiography is used to assess aortic 
disease, infective endocarditis, to find out source of embolism, 
abnormalities of mitral prostheses etc.  
 Stress echocardiography is done to find out new regional wall 
motion abnormalities, declining ejection fraction and increase in end 
systolic volume which are indicators of myocardial ischemia. 
 
. 
 F. COMPLICATIONS OF MYOCARDIAL INFARCTION 37 
1. ARRHYTHMIAS: 
A. TACHYARRYTHMIAS: 
a. Premature ventricular complexes: 
 The commonest arrhythmia is premature ventricular complexes. 
This can be suppressed with IV lignocaine 100mg given as bolus. To 
prevent recurrence lignocaine infusion of 500-1000mg in 500ml of 5% 
dextrose is administered at a rate of 1-2mg/min. premature ventricular 
complexes can be forerunners of life threatening ventricular tachycardia 
or ventricular fibrillation. 
b. Ventricular Tachycardia:(PH  6 ) 
 It needs immediate attention and should be treated by IV 
lignocaine. In case the drug is ineffective, DC shock of 150-200 joules 
will be effective in majority of the cases. Repeated attacks of 
ventricular tachycardia can be prevented by IV infusion of lignocaine, 
amiodarone or mexilitene. Ventricular pacing may also be effective. 
 
 
c. Ventricular Fibrillation:(PH7 )  
 The patient is pulseless and will have features of cardiac arrest. 
Immediate thump on the chest and an external cardiac massage is 
required. Defibrillation should be one by DC shock of 200-400 joules. 
Patients with repeated episodes may benefit from intravenous 
bretylium, amiodarone, mexilitene or lignocaine. 
d. Supraventricular Arrhythmias: 
 Atrial premature beats do not need specific treatment. However 
supraventricular arrhythmia, atrial flutter and atrial fibrillation require 
treatment with digoxin or verapamil. 
e. Accelerated Ventricular or Junctional Rhythm: 
 Normally pace maker cells in the AV junctional and ventricular 
myocardium have a rate of 40-60/min. however in the settings of 
myocardial infarction, especially in acute inferior wall myocardial 
infarction, the rate of these pacemakers increases to about 80-120/min. 
such a rhythm do not require specific treatment and is normally self 
limiting. If hemodynamic compromise occurs IV atropine (1.2mg) 
suppresses it by increasing the sinus rate. 
 
B. BRADYARRHYTHMIAS AND CONDUCTION 
DISTURBANCES: 
a. Sinus Node Dysfunction: 
 It may present as sinus bradycardia, sinus arrest or sinoatrial 
block usually due to vagal stimulation or in the settings of inferior wall 
infarction due to sinus node ischaemia. Symptoms of profound 
hypotension and shock may occur and occasionally asystole and cardiac 
arrest. Immediate treatment consists of IV atropine (1.2mg). If atropine 
is ineffective or this problem is persistent or recurring temporary pace 
making is necessary. 
b. AV Nodal Block: 
 It usually occurs with inferior wall myocardial infarction as first 
degree AV block, Wenkebach’s block or complete AV block. These 
blocks are usually transient and respond to IV atropine. If giddiness, 
hypotension or other evidence of hemodynamic compromise occurs or 
if the ventricular rate is less than 50/min temporary pacing may be 
required. 
c. Distal Conduction Disturbances: 
 The distal conduction system consists of the right bundle and the 
anterior and posterior fascicles of the left bundle. Since the major blood 
supply to this part of the conduction system comes from the left 
coronary artery, conduction defects in the bundle branches are common 
in anterior wall infarction. Block of one of the fascicles of the left 
bundle does not have an ominous prognosis. However acute right or left 
bundle branch block or bifascicular block carries an ominous prognosis. 
Block in the three fascicles results in complete heart block with an 
unstable ventricular escape rhythm at a rate of 20-40 beats per minute. 
Clinical manifestations consists of syncopal attacks, hypotension and 
may lead to cardiac arrest. Temporary pacemaker insertion is necessary. 
Temporary pacing is also indicated in patients who develop bifascicular 
blocks since this can be a precursor of trifascicular block. Patients with 
bifascicular block who develop trifascicular block may need permanent 
pacemaker implantation. 
2. ISCHAEMIA: 
 Post infarction angina occurs in upto 50% of patients. This is due 
to residual stenosis in infarct related vessel despite successful 
thrombolysis. 
3. ACUTE CIRCULATORY FAILURE: 
 Hemodynamic evidence of left ventricular dysfunction appears 
when contraction is seriously impaired in 20-25% of the left ventricle. 
Infarction of more than 40% of left ventricle results in Cardiogenic 
Shock which carries a bad prognosis. 
4. PERICARDITIS:(PH 1 ) 
 This may occur at any stage but is particularly common on the 
second and third day. The patient may recognize a different pain that is 
positional and worsens on inspiration. Dressler’s Syndrome may occur 
between 2 weeks and 3 months after acute myocardial infarction 46 and 
has an autoimmune basis often accompanied by pleural and pericardial 
effusions, fever and raised ESR. Treatment requires the use of steroids. 
 
5. MECHANICAL COMPLICATIONS: 
a. Mitral regurgitation:(PH 2 ) 
 It is due to ischaemia or rupture of papillary muscle and is 
recognized by the presence of systolic murmur at the apex. If trivial, it is 
of no hemodynamic significance. However severe mitral regurgitation 
can induce life threatening left ventricular failure and cardiogenic shock 
and may warrant urgent coronary angiography followed by coronary 
bypass surgery and mitral valve replacement. 
 
b. Ventricular septal defect: 
 It is a defect due to rupture of infarcted interventricular septum 
and is recognized by the presence of pansystolic murmur at the left 
sternal border. Diagnosis is possible by Echo-Doppler studies. It 
produces severe left heart failure and needs immediate surgical 
intervention. 
c. Cardiac Rupture: 
 It is a serious complication which results in cardiogenic shock and 
almost 100% mortality. Emergency treatment by pericardial tapping 
may prove life saving. Rare cases have been saved by emergency 
surgery. 
6. OTHER COMPLICATIONS: 
a. Left Ventricular Aneurysm: 
 The infarcted segments are dilated and show paradoxical 
movement and compromised left ventricular hemodynamics. It is 
recognized by persistent ST elevation in ECG and dyskinesia seen in 
echocardiography and radionuclide or contrast ventriculography. It may 
result in persistent left ventricular failure, arrhythmias and systemic 
embolism. Treatment consists of aneurysmectomy and associated 
coronary artery bypass surgery if so indicated. 
b. Thromboembolism:  
 Formation of a thrombus within the left ventricle followed by 
systemic arterial embolism leading to occlusion of a peripheral artery 
requires immediate surgical embolectomy in accessible vessels.
 Pulmonary embolism originates in the leg veins due to prolonged 
immobilization. These are prevented by anticoagulation. Massive 
embolism may result in shock and sudden death. Thrombolytic therapy 
and embolectomy are occasionally required. The condition can be 
prevented by low molecular weight heparin. 
HYPONATREMIA  IN MYOCARDIAL INFARCTION: 
Hyponatremia is defined as a decrease is serum sodium 
concentration to a level below 135 mEq/L. 
Serum sodium concentration and serum osmolarity are normally 
maintained by haemostatic mechanisms involving thirst, antidiuretic 
hormone (ADH) Renin angiotensin aldosterone  system  (RAAS) and 
renal handling of sodium and water. 
Increase in serum osmalarity above the normal (> 290 mosm/kg) 
stimulate hypothalamic osmoreceptors which in turn causes an increase in 
thirst and release of ADH. 
Hyponatremia is a common electrolyte disorder among 
hospitalized patients J.A. clayton et al.(2, 13) It also carries an increased  
mortality rate among the hospitalized patients (G.Gill et al.)(3). The 
prevalence of hyponatremia in hospitalized patients is 2% (CMDT 2006, 
p 866). It occurs equally in males and females(13). 
Congestive cardiac failure causes hypotonic, hypervolemic 
hyponatremia. Hyperglycemia is the most common cause of trans 
locational hyponatremia. An increase in 100 mg/dl in serum glucose 
concentration decreases serum sodium by 1.6 mEq/L with the end result 
of rise of serum osmolality of approximately 2 mosm/Kg of water. 
Retention of mannitol also has the same effect. 
After taking careful thorough history, including medication and 
clinical examination to look for volume status, patients may be subjected 
to biochemical investigations as follows : 
1) The initial laboratory measurement needed in the evaluation of 
hyponatremia is serum osmolality. The common cause of 
hyperosmolar hyponatremia (serum osmolality >290 mosm/kg) 
are hyperglycemia hypertonic solutions like mannitol. Iso-
osmolar hyponatremia is caused by hyperlipidemia and 
hyperproteinemia. Hypoosmolar hyponatremia can be again 
divided into three groups depending on volume status. 
2) Urine osmolality is the next measurement which can very well 
delineate many causes of hyposmolar hyponatremia.  
This index indicates whether water excretion is impaired or not. 
Normally when the body is faced with water load, serum 
osmolality is decreased, ADH is suppressed and excess free 
water is excreted in very dilute urine (osmolality as low as <50 
moml/kg). Patients with hyponatremia and urine osmomality of 
less than 100 mosm/kg are appropriately excreting very dilute 
urine as occurs in primary polydipsia and reseting of osmostat 
(i.e., a form of SIADH). However most patients with 
hyponatremia have urine osmolality or more than 200 mosm/kg 
reflecting impairment of water excretion. 
 
3) The final step in evaluation of hyponatremia is to measure the 
urine sodium concentration and using this in conjunction with 
volume status to determine the cause of hyponatremia. This can 
help to guide therapy. In general, a spot test showing urine 
sodium concentration of <30 mEq/L differentiates patients with 
hypovolemic hyponatremia from patients with euvolemic 
hyponatremia. 
 
Mechanism of hyponatremia in acute MI : 
 It is not clear whether the mechanisms that contribute to the 
development of hyponatremia in heart failure are involved in 
acute myocardial infarction. Increased hypothalamic expression 
of vasopressin and up-regulation of water channels in the 
collecting duct require several weeks of heart failure to 
develop(4). However many patients developed acute 
hyponatremia during AMI either at admission or later during the 
hospital stay. 
Flear CT et al. (7) found that hyponatremia developed in patients 
with AMI and it adversely affected the outcome of patients. Also he 
stated that mortality increases when the level of serum sodium fell below 
130 mEq/L. 
Similar study by Wan LF et al. from China classified AMI patients 
who had developed hyponatremia during their hospital stay into two 
groups depending on the degree of hyponatremia, and ultimately found 
that mortality increased with the degree of hyponatremia. 
Goldberg et al.(4) from Israel in his study with large patients 
number found that hyponatremia was found in 12.5% of patients with 
AMI and developed in 19.9% during first 72 hours of hospital stay. 
According to Satish et al., for South India hyponatremia developed 
in 18.5% patients with AMI on admission and 0.8% patients developed 
hyponatremia during initial 72 hours. 
According to Schaler MD et al.(12), plasma arginine vasopressin 
level increases after acute myocardial infarction. The probable reasons 
put forth by Goldberg et al.(4) for elevated arginine vasopressin level was 
pain, nausea, major stress, acute development of LV dysfunction and in 
response to administration of NSAIDs and diuretics.  
Rowe JW et al.(26) and Madias et al.(14) also related vasopressin 
release with emetic reflex and also following diuretic intake respectively. 
However level of vasopressin didn’t correlate with plasma osmolality(12) 
in patients of AMI. Hence it was proposed that, the non osmotic release 
of vasopressin due to carotid baroreceptors stimulation may cause 
hyponatremia in  patients with acute STEMI(4). 
Along with vasopressin release, neurohumoral activation occurs 
following AMI involving renin angiotensin – Aldosterone system and nor 
epinephrine release contribute to hyponatremia following AMI (26,27). 
Hence acute hyponatremia following acute STEMI can be 
explained on the basis of non osmotic release of vasopressin, further 
aggravated by, concomitant activation of the renin angiotensin 
aldosterone system (RAAS) and increased norepinephrine production. 
These factors decrease the glomerular filtration rate, and subsequent 
delivery of tubular fluid to the diluting segment of the nephron, further 
contributing to decreased renal water excretion(10). 
As already mentioned, limited number of studies were executed 
worldwide to find out the prevalence of hyponatremia in acute STEMI 
and also its correlation with 30 day (short term) mortality. 
Goldberg et al.(4) in his largest series of 1067 patients admitted 
with acute STEMI had considered all the possible factors that could affect 
short term mortality among AMI patients like diabetes mellitus, female 
sex, smoking, hypertension, previous CAD/LVD, anterior infarction, 
killip scorings, reperfusion therapy etc. along with acute hyponatremia 
that developed after acute STEMI and concluded that hyponatremia is an  
independent risk factor for 30 days (short term) mortality among acute 
STEMI patients. 
A retrospective study from China, Wang LF et al., in 2006 
analysed acute hyponatremia along with enzymes level, infarct size, 
cardiac function and found that as the degree of hyponatremia increases, 
the short term mortality (30 days mortality) increases. He concluded that 
hyponatremia may be considered as one of the important markers that 
predict a worst prognosis in AMI. 
Similar study by Flear CT, Hilton P(7) in 1979 in the series of 235 
patients admitted for AMI found that day to day variability of serum 
sodium was often increased and also concluded finally that short term 
mortality increases with degree of hyponatremia (<130 mEq/L). However 
in this study he didn’t consider LV dysfunction as one of the factors for 
short term mortality among AMI patients. 
A limited study from Satish et al. from South India of about 54 
patients, concluded that hyponatremia can be considered as an 
independent risk factor following acute STEMI. 
Laurie Barday and Charles Vega(28) analyzed a parallel study by 
Goldberg et al.(29) correlating hyponatremia in early phase of STEMI with 
long term mortality and post discharge admission for cardiac failure. In 
this series of 978 patients with acute STEMI, without a history of heart 
failure. 11% had hyponatremia (<72 hrs of admission). Patients were 
followed up from 9-61 months (mean 31 months). It was found that 
overall mortality for hyponatremic patients was 24.1% as against (0.9%) 
for normonatremic patients. 11.7% of hyponatremic patients developed 
heart failure during their follow up period. Laurie Barday and Charles 
Vegas on the basis of Goldberg et al., study concluded that hyponatremia 
within 72 hours of acute STEMI was an independent factor for long term 
mortality and hospitalization for heart failure following AMI. However 
and its risk increased with the degree of hyponatremia. However, it was 
not a significant risk factor for promoting recurrent myocardial infarction. 
                     The correlation of possible factors like age, LVD, female 
sex, anterior infarction etc, that can affect the short term mortality of 
acute STEMI have been studied exhaustively worldwide and are proved 
beyond doubt(32). 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIAL AND METHODS 
The study is designed to evaluate the correlation of serum sodium 
level with 30 days mortality, and with cardiac events that occur during 
hospital stay among acute STEMI patients. 
During the period from 1st Jan 2008 to 30th Jun 2009, 100 patients 
admitted with acute myocardial infarction in coronary care unit, CMC 
Hospital, Coimbatore ,within a period of three days who fulfilled the 
inclusion / exclusion criteria were analysed. The patients were divided 
into two equal groups. 
  
100 patients admitted in ICCU, Department of Cardiology, 
Coimbatore Medical College, Coimbatore, who fulfilled the inclusion / 
exclusion criteria were enrolled. The patients were divided into two equal 
groups. 
 
1. Group A : Patients with hyponatremia on admission or developed 
during first 72 hours of acute STEMI. 
2. Group B : Patients with normal serum sodium level during the first 
72 hours of acute STEMI. 
 
 INCLUSION CRITERIA : 
Patients having acute STEMI defined by ST segment elevation of 
>2 mm in precordial leads, (or) >1 mm in frontal leads in 2 or more 
consequtive leads with or without Q waves in standard electrocardiogram 
(ECG) with any one of the following. 
(a) Typical chest pain suggestive of angina lasting for more than 20 
minutes, (or) anginal equivalents like breathlessness, chest 
discomfort or sweating. 
 
(b) Raised cardiac enzymes (CPK-MB, Troponin I or T). 
 
(c) Fresh regional wall motion abnormalities in Echocardiogram 
(ECHO). 
EXCLUSION CRITERIA : 
1. Patients with co-morbid conditions like previously detected 
CCF, LV dysfunction, renal disease, decompensated liver 
disease, fresh cerebrovascular accidents, malignancies, acute 
gastroenteritis  
2. Patients on any medications that alter serum sodium level like 
diuretics, steroids, antacids ACE inhibitors, amiodarone, 
clofibrate etc. 
3. Patients with very late presentation of acute STEMI. 
4. Patient with acute onset LBBB. 
Patients fulfilling inclusion criteria were subjected to thorough 
history, clinical examination biochemical investigations, ECG, Chest X-
ray and ECHO  Biochemical investigations. 
1. Complete blood count. 
2. Blood sugar by glucose oxidase method. 
3. Blood urea. 
4. Serum creatinine. 
5. Serum sodium by ion specific electrode method 
6. Cardiac Enzymes (CPK MB, Troponin I or T) if required. 
7. Lipid profile. 
8. X-ray chest.( fig 1 ) 
9. ECG.( fig 2-7 ) 
 
Types of Myocardial infarction on the basis of ECG are as follows : 
(a) Q or ST elevation in V1-V6 – Anterior wall MI. 
(b) Q or ST elevation in V1-V4 – Anteroseptal MI. 
(c) Q or ST elevation in II, III, avf – Inferior wall MI.( fig 5 ) 
(d) Q or ST elevation in I, AVL, V5-V6 – Lateral wall MI.( fig 3 ) 
(e) R>S, ST Depression and upright T in V1-V2– Posterior wall MI  
(f) ST elevation >1 mm in V1 and RV4 – Right ventricular MI. 
(g) Q (or) ST elevation in I, AVL and V1-V6   –       Extensive 
anterior wall MI.(fig 4 ) 
10. Echocardiogram (ECHO): Patients were subjected to ECHO 
on   day 3. 
Venous samples for serum sodium were obtained on admission, 24 
hours, 48 and 72 hours. Thereafter blood sugar levels were determined 
simultaneously and serum sodium levels were corrected by adding 1.6 
mEq/L for every 100  mg/dl increase in blood sugar above 100 mg/dl. 
Hyponatremia is defined as serum sodium level below 135 mEq/L. 
Patients were then followed up after 30 days, either personally or 
through telephone and cardiac events were recorded. 
 
 
RESULTS AND ANALYSIS 
 
HYPONATREMIA FOLLOWING ACUTE MYOCARDIAL 
INFARCTION 
 According to the level  of serum sodium  patients were classified into 
the following groups(TABLE )  
TABLE 1 
SEX DISTRIBUTION AMONG PATIENTS WITH NORMAL 
AND LOW SODIUM LEVELS 
Gender Normonatremia Hyponatremia Total 
Male 55 (80.9%) 27 (84.4%) 82 (82.0%) 
Female 13 (19.1%) 5 (15.6%) 18 (18.0%) 
Total 68 (100.0%) 32 (100.0%) 100 
 
Out of all 100 MI patients, 32(32.0%) had hyponatremia in any of 3 
days values. And 68 (68.0%) had completely normal sodium levels in all 
3 days. Out of those 32 hyponatremics, 27(84.4%) were males and 
5(15.6%) were females. And out of those 68, 55(80.9%) were males and 
13(19.1%) were females.  
 Table 2 
Types of Myocardial Infarction among Male and Females 
Territory of MI Male % Female % Total % 
ASMI 18 22.0 6 33.3 24 24.0 
AWMI 39 47.6 8 44.4 47 47.0 
ALMI 4 4.9 1 5.6 5 5.0 
IWMI 19 23.2 2 11.1 21 21.0 
PWMI 2 2.4 1 5.6 3 3.0 
Total 82 100.0 18 100.0 100 100.0 
 
  
Table 3 
Type of MI in hyponatremics among Males and Females   
Territory of MI Male % Female % Total % 
ASMI 4 14.8 0 0.0 4 12.1 
AWMI 17 63.0 2 33.3 19 57.6 
ALMI 3 11.1 1 16.7 4 12.1 
IWMI 2 7.4 2 33.3 4 12.1 
PWMI 1 3.7 1 16.7 2 6.1 
TOTAL 27 100.0 6 100.0 33 ( 32 pts ) 100.0
 
Within the MI s male female ratio were studied. One patient had 
combined high lateral MI and ASMI. The patients who had  
hyponatremia were 32 and MIs were 33.in that AWMI were the highest. 
 
(ONE PATIENT HAD A COMBINED  ASMI WITH HIGH LATERAL 
WALL MI.) 
TABLE 4 
SHORT TERM MORTALITY IN NORMO AND 
HYPONATREMIC PATIENTS  
Mortality Hyponatremia % Normonatremia % Total % 
Alive 24 75.0 48 70.6 72 72.0 
Death 8 25.0 20 29.4 28 28.0 
Total 32 100.0 68 100.0 100 100.0
  
FIG. 5.  SHORT TERM MORTALITY AMONG HYPONATREMIC PATIENTS  
 
TABLE 5 
TYPE OF MI WITH HYPONATREMICS AND ITS 
CORRELATION WITH DAY OF HYPONATREMIA 
Hyponatremia at .Territory 
of MI TOTAL Hyponatremia Day 1 Day 2 Day 3 
ASMI 24 4 2 (50.0%) 
1  
(25.0%) 
1 
(25.0%) 
AWMI 47 19 14 (73.7%) 
1 
(5.3%) 
4 
(21.1%) 
ALMI 05 4 2 (50.0%) 0 
1 
(25.0%) 
IWMI 21 4 3 (75.0%) 0 
1 
(25.0%) 
PWMI 03 2 1 (50.0%) 0 
1 
(50.0%) 
Total 100 33(32 patients) 
22 
(68.8%) 
2 
(6.3%) 
8 
(25.0%) 
 
FIG 6. 
DAY OF HYPONATREMIA WITH TERRITORY OF MI 
 
 TABLE 6 
DEGREE OF HYPONATREMIA WITH TERRITORY OF MI 
Severity of Hyponatermia Territory of 
MI TOTAL Hyponatremia 131 – 135  125 – 130  
ASMI 24 4 1 (25.0%) 3 (75.0%) 
AWMI 47 19 13 (68.4%) 5 (26.3%) 
ALMI 05 4 3 (75.0%) 1 (25.0%) 
IWMI 21 4 2 (50.0%) 2 (50.0%) 
PWMI 03 2 0 2 (100.0%) 
Total 100 33 19 (59.4%) 13 (40.6%) 
 
FIG 6 
DEGREE OF HYPONATREMIA WITH TERRITORY OF MI 
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TABLE - 7 
AGE, HYPONATREMIA AND MORTALITY 
Hyponatremia (N=32) Normonatremia (N=68) 
 
Total 
Male Female Male Female 
< 30 2 1 (3.8%) 0 0 1 (6.7%) 
31-40 17 2 (7.7%) 1 (16.7%) 12 (22.6%) 2 (13.3%) 
41-50 31 11(42.3%) 1(16.7%) 14 (26.4%) 5 (33.3%) 
51-60 35 10 (38.5%) 2 (33.3%) 17 (32.1%) 6 (40.0%) 
61-70 15 2 (7.7%) 2 (33.3%) 10 (18.9%) 1 (6.7%) 
TOTAL 100 26 (100.0%) 6 (100.0%) 53 (100.0%) 15 (100.0%) 
One from less than 30 years was hyponatremic and one 
normonatremic.in 31-40 yrs group 3 out of 17 was hyponatremic. In 41-
50 yrs 12 out of 31 was hyponatremic. In 51-60 yrs group 12 out of 35 
was hyponatremic. 1n 61-70 yrs 4 out of 15 developed hyponatremia. 
Fig. 8 AGE, HYPONATREMIA AND MORTALITY 
 
The male female ratio was also studied. The proportion of the males was 
more in 41 – 60 yrs groups. In younger groups the female ratio was less. 
Table  8  
AGE, HYPONATREMIA AND MORTALITY 
Age Hyponatremia (N=32) Alive Death 
< 30 1 1 (100.0%) 0 
31-40 3 3 (100.0%) 0 
41-50 12 7 (58.3%) 5 (41.7%) 
51-60 12 7 (58.3%) 5 (41.7%) 
61-70 2 1 (50.0%) 1 (50.0%) 
 
Fig. 9 AGE, HYPONATREMIA AND MORTALITY 
 
 
 
DIABETES 
 
TABLE NO. 9 
SEX DISTRIBUTION OF MI PATIENTS IN  DIABETES 
 
 
 
 
FIG.10 SEX DISTRIBUTION OF MI PATIENTS IN  DIABETES 
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Gender Number percentage 
Male 12 80.0 
Female 3 20.0 
Total 15 100.0 
Fig. 11 HYPONATREMIA AMONG DIABETES 
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Table 10 
HYPONATREMIC PATIENTS AMONG DIABETES VS DAY 
Gender Total DAY 1 DAY 2 DAY 3 
Male 4 2 (50.0%) 2 (50.0%) 4 (100.0%) 
Female 1 1 (100.0%) 0 0 
Total 5 3 (60.0%) 2 (40.0%) 4 (100.0%) 
 
 
 
 
 
 
 
Fig. 12 
HYPONATREMIC PATIENTS AMONG DIABETES VS DAY 
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TABLE 11 
HYPONATREMIA AMONG DIABETES VS SHORT TERM 
MORTALITY: 
 
Mortality Hyponatremia Normonatremia Total 
Alive 3 (60.0%) 7 (70.0%) 10 (66.7%) 
Death 2 (40.0%) 3 (30.0%) 5 (33.3%) 
Total 5 (100.0%) 10 (100.0%) 15 (100.0%) 
 
 
 
 
 
FIG. 13 
HYPONATREMIA AMONG DIABETES VS SHORT TERM 
MORTALITY: 
 
FIG. 14 
HYPONATREMIA AMONG DIABETES VS SHORT TERM 
MORTALITY: 
 
 
CORONARY ARTERY DISEASE: 
 
TABLE 12 
CAHD HISTORY VS SEX RATIO 
Gender Number percentage 
Male 4 80.0 
Female 1 20.0 
Total 5 100.0 
 
FIG. 15 
CAHD HISTORY VS SEX RATIO 
 
 
 
 
 
 
 
 FIG. 17 
CAHD HISTORY VS SEX RATIO 
 
TABLE 13 
HYPONATREMICS  AMONG OLD CAHDS : 
 
Gender Total Number Percentage 
Male 4 1 25.0 
Female 1 1 100.0 
Total 5 2 40.0 
 
 
 
  
 
FIG. 17 
CAHD HISTORY VS SEX RATIO 
 
 
TABLE 14 
HYPONATREMICS AMONG OLD CAHD VS DAY : 
Gender Total DAY 1 DAY 2 DAY 3 
Male 1 1 1 1 
Female 1 1 0 0 
Total 2 2 1 1 
 
 
 
 
 
 
 FIG. 15 
CAHD HISTORY VS SEX RATIO 
 
TABLE 15 
HYPONATREMICS AMONG OLD CAHDS VS SHORT TERM 
MORTALITY: 
Mortality Hyponatremia Normonatremia Total 
Alive 1 (50.0%) 3 (100.0%) 4 (80.0%) 
Death 1 (50.0%) 0 1 (20.0%) 
Total 2 (100.0%) 3 (100.0%) 5 (100.0%) 
χ2=1.50 , p=0.2206 
 
 
 
 
FIG. 19 
HYPONATREMICS AMONG OLD CAHDS VS SHORT TERM 
MORTALITY: 
 
 
Out of 2 hyponatremics one was alive and the other was dead. 
 
 
THROMBOLYSIS: 
 
Fig. 20 
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TABLE 16 
THROMBOLYSIS VS SEX RATIO 
 
Gender Number percentage 
Male 33 89.2 
Female 4 10.8 
Total 37 100.0 
 
 
 
 
 Fig. 21 
THROMBOLYSIS VS SEX RATIO 
 
 
 
TABLE 17 
HYPONATREMICS AMONG THROMBOLYSED : 
Gender Total Hyponatremia Percentage 
Male 33 12 36.4 
Female 4 02 50.0 
Total 37 14 37.8 
 
 
  
 
Fig. 22 
HYPONATREMICS AMONG THROMBOLYSED : 
 
 
TABLE 18 
HYPONATREMIA AMONG THROMBOLYSED VS SHORT 
TERM MORTALITY : 
Mortality Hyponatremia Normonatremia Total 
Alive 8 (57.1%) 16 (69.6%) 24 (64.9%) 
Death 6 (42.9%) 7 (30.4%) 13 (35.1%) 
Total 14 (100.0%) 23 (100.0%) 37 (100.0%)
 
 
 
 
 
 
FIG. 23 
HYPONATREMIA AMONG THROMBOLYSED VS SHORT 
TERM MORTALITY : 
 
 
 LV DYSFUNCTION 
EJECTION FRACTION: 
TABLE 19 
AGEWISE DISTRIBUTION OF LVEF WITH SEX RATIO 
 
EF IN % MALE FEMALE TOTAL
< 30 4 1 05 
30-35 3 0 03 
36-40 9 4 13 
41-45 5 2 07 
46-50 10 1 11 
51-55 8 3 11 
56-60 27 4 31 
61-65 13 1 14 
66-70 3 2 05 
TOTAL 82 18 100 
 
 
 
 
 
 
 
 
 
 
 Fig. 24 
AGEWISE DISTRIBUTION OF LVEF WITH SEX RATIO 
 
TABLE 20 
EJECTION FRACTION < 50 % 
Gender Total Number Percentage 
Male 82 27 32.9 
Female 18 8 44.4 
Total 100 35 35.0 
 
 
 
 
 
Fig. 25 
SEX RATIO AMONG LV DYSFUNCTION 
 
 
 
TABLE 21 
HYPONATREMIC PATIENTS AMONG LVDS 
 
Gender Total Hyponatremia percentage 
Male 27 13 48.1 
Female 8 4 50.0 
Total 35 17 48.6 
 
 
 
 
 
FIG. 26 
HYPONATREMIC PATIENTS AMONG LVDS 
 
 
 
 
TABLE 22 
HYPONATREMICS AMONG LVDS VS MORTALITY: 
Mortality Hyponatremia Normonatremia Total 
Alive 6 (35.3%) 7 (38.9%) 13 (37.1%) 
Death 11 (64.7%) 11 (61.1%) 22 (62.9%) 
Total 17 (100.0%) 18 (100.0%) 35 (100.0%)
 
 
 
 
FIG. 27 
 HYPONATREMICS AMONG LVDS VS MORTALITY: 
 
TABLE 23 
SHORT TERM MORTALITY: 
Mortality Male Female Total 
Alive 58 (70.7%) 14 (77.8%) 72 (72.0%) 
Death 24 (29.3%) 4 (22.2%) 28 (28.0%) 
Total 82 (100.0%) 18 (100.0%) 100 (100.0%) 
 
 
 
 
 
 
 
FIG. 28 
SHORT TERM MORTALITY: 
 
 
 
 
TABLE.24 
HYPONATREMIA VS SHORT TERM MORTALITY 
Mortality Hyponatremia Normonatremia Total 
Male 8 (72.7%) 16 (94.1%) 24 (85.7%) 
Female 3 (27.3%) 1 (5.9%) 4 (14.3%) 
Total 11 (100.0%) 17 (100.0%) 28 (100.0%)
 
 ADVERSE CARDIAC EVENTS: 
TABLE.25 
SEX RATIO AMONG ADVERSE CARDIAC EVENTS 
Gender Total Number of Cardiac Events percentage 
Male 82 17 20.7 
Female 18 5 27.7 
Total 100 22 22.0 
 
FIG 31 
SEX RATIO AMONG ADVERSE CARDIAC EVENTS 
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TABLE.26 
HYPONATREMCS AMONG ADVERSE CARDIAC EVENTS 
 
 
Gender Total Hyponatremia Total 
Male 17 6 35.3 
Female 5 3 60.0 
Total 22 9 40.9 
 
 
 
 
 
FIG.32 
HYPONATREMCS AMONG ADVERSE CARDIAC EVENTS 
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MORTALITY WITH DAY OF HYPONATREMIA: 
TABLE.27 
Gender Total DAY 1 DAY 2 DAY 3 
Alive 14 14 (100.0%) 3 (21.4%) 8 (57.1%) 
Death 8 8 (100.0%) 8 (100.0%) 8 (100.0%) 
Total 22 22 (100.0%) 11 (50.0%) 16 (72.7%) 
 
 
 
 
FIG 33 
MORTALITY WITH DAY OF HYPONATREMIA: 
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RHYTHM ABNORMALITIES (N=100) : 
Incidence of hyponatremia and normonatremia in cases of rhythm 
abnormalities 
TABLE 28 
RHYTHM ABNORMALITIES AMONG HYPONATREMIC 
PATIENTS 
 Hyponatremia Normonatremia Total 
Bradyarrythmias  
Fascicular 
Block 1 (14.3%) 6 (85.7%) 7 (100.0% 
Av Block 3 (50.0%) 3 (50.0%) 6 (100.0%) 
Tachyarrythmias  
SVT/AF 0 3 (100.0%) 3 (100.0%) 
VT/VF 
4 (80.0%) 1 (20.0%) 5 (100.0%) 
 
DISCUSSION 
 
Out of all 100 MI patients, 32(32.0%) had hyponatremia in any of 3 
days values. And 68 (68.0%) had completely normal sodium levels in all 
3 days. Out of those 32 hyponatremics, 27(84.4%) were males and 
5(15.6%) were females. And out of those 68, 55(80.9%) were males and 
13(19.1%) were females.  
TYPES OF MI IN THE STUDY GROUP  (TABLE 2,3)(FIG 2,3) 
Out of all MI patients 82 were males and 18 were females. Out of all 
MIs anteroseptal MI were around 24 , AWMI 47 ,  ALMI 5 , IWMI 21 , 
AND PWMI 3 
Within the MI s male female ratio were studied. One patient had 
combined high lateral MI and ASMI. The patients who had  
hyponatremia were 32 and MIs were 33.in that AWMI were the highest 
in the male group (63 %) and AWMI & IWMI were the same in the 
female group ( 33.3 % ) 
 
 
 
SHORT TERM MORTALITY IN NORMO AND 
HYPONATREMICS (TABLE 4)(FIG 4,5) 
Among hyponatremics 75 % were alive and among normonatremics 70 % 
were alive. The short term mortality rate for hyponatremics and 
normonatremics  were 25 % and 28 % respectively. 
TYPE OF MI WITH HYPONATREMICS AND ITS 
CORRELATION WITH DAY OF HYPONATREMIA(TABLE 
5,6)(FIG 6) 
The territory of MIs were studied with days of hyponatremia. Certain 
patients had hyponatremia in all 3 or 2 days among 3 days of 
hyponatremia. The first day of hyponatremia is taken into account. In this 
regard , out of all 48 AWMI s , 19 had hyponatremia. This is divided 
within 3 days as 14,1,4 respectively. 
Out of all 4 ASMIs with hyponatremia , the distribution within days were 
2,1,1 respectively Out of all 3 anterolateral MIs with hyponatremia , the 
distribution were 2,0,1 respectively Among  4 IWMIs with hyponatremia 
, the distribution were 3,0,1 respectively Among  PWMIs with 
hyponatremia , the distribution were 1,0,1respectivel Among 100 MIs , 
32 had hyponatremia.  
Out of all 32 hyponatremia  , 22 ( 68.8 % ) had on the first day, 6.3 % on 
the second day , 8 % on the third day. PWMI had hyponatremia equally 
on first and the third day.  
DEGREE OF HYPONATREMIA WITH TERRITORY OF MI  
(FIG 7) 
The hyponatremia was classified into A ( 131 – 135 ) and B ( 125 – 130 ) 
to compare with the MI with severity. 
ASMI had the highest incidence ( 75% ) of severe hyponatremia and 
ALMI had the least incidence ( 25% ) of severe hyponatremia. 
AGE , HYPONATREMIA AND MORTALITY(TABLE 7,8)  
(FIG 8,9) 
Maximum cases of hyponatremia were in 41 – 50 yrs group in males 
and 51 – 70 yrs in females.  
Coming to mortality in hyponatremics among age groups 41 – 60 yrs 
which had the highest incidence of hypos among both sexes the 
mortality was 58.3 % and 100 % in less than 40 yrs group.  
 
 
DIABETES , HYPONATREMIA AND MORTALITY(TABLE 
9,10,11)(FIG 10-14) 
Out of 100 patients studied 15 were diabetics. Out of which 12 were 
males and 3 were females. Out of 15 diabetics 5 were hyponatremic. 
Out of those 5 , 4 were males and 1 was a female. Out of 5 
hyponatremics among diabetics 3 were Alive and 2  died. 
CAHD HISTORY AND HYPONATREMIA , 
MORTALITY(TABLE 12-15)(FIG 15-19) 
Out of 100 in the study population 5 had old history of coronary heart 
disease. Out of those 4 were males and one was a female Out of 5 old 
CAD  patients 2 developed hyponatremia. Out of which 1 was a male 
and the other a female Out of 5 old CAD patients 1 male developed 
hyponatremia and 1 female developed hyponatremia. The male 
hyponatremia persisted for all three days and the female hyponatremia 
persisted for only a single day. Out of 2 hyponatremics one was alive 
and the other was dead. 
 
 
 
THROBOLYSIS AND HYPONATREMIA, MORTALITY(TABLE 
16-18) (FIG 20-23) 
Out of all MI patients 37 were thrombolysed based upon the inclusion 
and exclusion criteria .  Out of those 37 , 33 were males and 4 were 
females. Out of 37 who were thrombolysed 14 developed hyponatremia 
. out of those 14 8 were alive and 6 expired. 
LV DYSFUNCTION (TABLE 19-22)(FIG 24-27) 
LV Dysfuction is defined in our study as LVEF less than 50% as routine 
ECHO was done for all patients with MI Out of all 100 MIs patients , 35 
patients had LVEF less than 50%. The male female ratio was 27 : 8 The 
incidence of hyponatremia was studied among those had LVEF less than 
50%. Total hyponatremias were 17 where male female ratio was 13 :4 
Then the incidence of mortality was studied among those who had 
hyponatremia among low LVEF. Out of all 35 low LVEF , 17 had 
hyponatremia.  Out of this 17 , 11( 64.7 % ) expired  and 6 ( 35.3 % ) 
are alive.  
ADVERSE CARDIAC EVENTS(TABLE 25,26)(FIG 31,32) 
Out of all MIs 22 patients developed adverse cardiac events such as 
arrhythmias , new onset failures during hospital stay. Out of those 22 , 
17 were males and 5 were females. 
Out of those 22 who developed adverse cardiac events 9 developed 
hyponatremia during hospital stay. The male female ratio was 2 : 1. 
HYPONATREMICS AMONG MORTALITY (TABLE 23,24)(FIG 
28-30) 
Out of all MI s 72 were alive at 30 days follow up and 24 expired at 30 
days follow up. Out of 72 , 58 were male and 14 were females. Out of 
28 , 24 were males and 4 were females.  
Out of all 28 who expired within 30 days 11 developed hyponatremia 
during hospital stay. Out of those 11 ( 39% ), 8 (72 % ) were males and 
3 (27 % ) were females. 
 
RHYTHM ABNORMALITIES(TABLE 28) 
Incidence of hyponatremias in patients developed rhythm abnormalities 
were studied. Out of those rhythm abnormalities fascicular blocks were 
7 where one had hyponatremia. In patients with AV blocks totally 6 , 3 
had hyponatremia. With patients with SVT/AF , no one had 
hyponatremia. From 5 patients with VT/VF , 4 had hyponatremia 
 
 
 
 
 
 
 
CONCLUSION 
 
1. The short term mortality among  patients who had hyponatremia 
who had LV dysfunction was higher when compared to patients 
who had normal sodium levels who had LV dysfunction. 
 
2. The incidence of adverse cardiac events within first 72 hours  was 
the same between patients who had hyponatremia and patients who 
had normal sodium levels among STEMI patients  
 
3. Short term mortality among  MI patients who had hyponatremia 
increases as the age advances with highest incidence in the 61 – 70 
yrs age group. 
 
4. Assessment of serum sodium levels, thus must be carried out in all 
cases of acute STEMI so as to correct hyponatremia if present and 
there by preventing treatable complications and reducing mortality.  
 
 
